Asceneuron to take part in a panel discussion on clinical trials at the 10th International Conference on Frontotemporal Dementias on August 31 – September 2, 2016, in Munich, Germany

Dr. Beher, CEO will lecture on O-GlcNAcase Inhibitors for Tauopathies.

The International Conference on Alzheimer’s Drug Discovery brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion.